The World Vaccine Congress Europe brings together global leaders across the vaccine ecosystem to address scientific, manufacturing, and public health challenges. The agenda spans from pre-clinical breakthroughs and clinical trial strategies to bioprocessing and manufacturing innovations, including formulation, adjuvants, mRNA platforms, and decentralized production. Tracks also cover emerging and re-emerging diseases, AMR, global health, and veterinary vaccines, emphasizing preparedness and equity in vaccine access. In addition, immune profiling and new technologies like AI, RNA platforms, and synthetic biology are explored to accelerate discovery and personalization.

The event also spotlights bio-pharma showcases, cancer immunotherapy, respiratory vaccines, and COVID-19 preparedness, while offering in-depth working groups on supply chain solutions, public-private partnerships, and access strategies. Attendees gain insights into advancing innovation from bench to market, building collaborations, and shaping the future of vaccine science and delivery.

Stop by booth 433 to connect with our experts and discover solutions for every stage of vaccine innovation.

Register